{"url_path":"/sec/anvs/8-k/2026-05-20/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1477845/0001104659-26-064514-index.html","accession_number":"0001104659-26-064514","cik":"0001477845","ticker":"ANVS","issuer_name":"Annovis Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1477845/0001104659-26-064514-index.html","primary_entity_key":"0001477845","primary_entity_name":"Annovis Bio, Inc."},"word_count":120,"has_tables":true,"body_markdown":"**Item 7.01**\n**Regulation FD Disclosure**\n\n \n\nOn May 19, 2026, the Company issued a press release announcing the\nlaunch of the Offering. On May 20, 2026, the Company issued a press release announcing the pricing of the Offering. Copies of the press\nreleases are furnished as Exhibits 99.1 and 99.2 to this Current Report on Form 8-K and is incorporated by reference herein.\n\n \n\nThe information contained in this Item 7.01 shall\nnot be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),\nor incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific\nreference in such a filing."}